Stories from Bad Vilbel

02.12.2019 – 09:11
Stada Arzneimittel
STADA to Become a Major Pharma Player in Ukraine by Acquiring Biopharma's Pharmaceutical Prescription and Consumer Health Business
more
One document
06.11.2019 – 15:27
Stada Arzneimittel
Press release: STADA recognized as "Company of the year, EMEA" for the second year in a row
Press release STADA recognized as "Company of the year, EMEA" for the second year in a row Bad Vilbel, November 6, 2019 - This year, at the sixth Global Generics & Biosimilars Awards, STADA Arzneimittel AG was once again able to impress the independent jury and, as was the case in the previous year, was ...
more
One document
06.11.2019 – 14:39
Stada Arzneimittel
Press release: Alvotech and STADA agree on strategic biosimilar partnership
more
One document
05.11.2019 – 08:03
Stada Arzneimittel
Press release: STADA invests $660 Million USD in Takeda's OTC portfolio in Russia/CIS to become a major player in these branded markets
Press release STADA invests $660 Million USD in Takeda's OTC portfolio in Russia/CIS to become a major player in these branded markets - STADA to acquire a portfolio of approximately 20 selected OTC and prescription pharmaceutical products in Russia, ...
more
One document
04.11.2019 – 09:06
Stada Arzneimittel
Press release: STADA to acquire Walmark - a leading Consumer Healthcare company in Central Europe
more
One document
14.08.2019 – 07:33
Stada Arzneimittel
Press Release - STADA Delivers Strong First-Half 2019 Results
Press Release STADA Delivers Strong First-Half 2019 Results With reported sales growth of 11 percent in the first-half of 2019, STADA is performing well above the industry average. - 11 percent sales growth and a significant 13 percent increase in adjusted EBITDA - growth driven by both the brands/OTC segment and the generics business - Portfolio expansion ...
more
One document
04.07.2019 – 10:35
Stada Arzneimittel
Press release - STADA and BioQ Pharma launch Propofusor anesthetic in Australia
Press release STADA and BioQ Pharma launch Propofusor anesthetic in Australia - STADA Pharmaceuticals Australia launches the propofol product Propofusor on the Australian market together with its manufacturer BioQ Pharma Incorporated. - On Friday, June 28th, BioQ Pharma announced that the Australian ...
more
One document
25.06.2019 – 08:44
Stada Arzneimittel
Press release - Eelco Ockers appointed Executive Vice President Germany at STADA
more
One document
31.05.2019 – 09:06
Stada Arzneimittel
Press Release - Strategic Biosimilar Development Partnership: STADA and Xbrane strengthen collaboration
Press Release Strategic Biosimilar Development Partnership: STADA and Xbrane strengthen collaboration - Evaluation of potential development and commercialization collaborations around Xbrane's preclinical biosimilars Xcimzane and Xdivane and other ...
more
One document
15.05.2019 – 12:00
Stada Arzneimittel
STADA Health Report 2019: Half of Europeans are ready for Dr Robot and treatments via webcam
Bad Vilbel (ots) - - 56 percent of Europeans would undergo surgery with "Dr Robot" - 54 percent would receive treatment from their GP via webcam - 80 percent would take a gene test but only one quarter knows what a gene test can detect - Overall, men are more open to medical trends and new health technologies than women - 53 percent of Europeans feel optimistic about ...
more
11.10.2018 – 09:43
Stada Arzneimittel
Press release - STADA wins 2018 Global Generics & Biosimilars Award in "Company of the Year, EMEA" category
Press release STADA wins 2018 Global Generics & Biosimilars Award in "Company of the Year, EMEA" category Bad Vilbel, October 11, 2018 - STADA Arzneimittel AG fared well at this year's Global Generics & Biosimilars Awards and was named "Company of ...
more
One document

1